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Background and aims: 
Out-of-hospital cardiac arrest (OHCA) is a major public health issue, affecting almost 300,000 victims per 
year in Europe, who have an overall survival rate of about 10 per cent. In general, the current Emergency 
Medical Services (EMS) do not have the capacity to act quickly and effectively enough in regard to this vast 
group of patients. The objectives of the current work were: to study the importance of bystander 
cardiopulmonary resuscitation (CPR) from a national perspective; to determine the safety, feasibility and 
efficacy of trans-nasal evaporative cooling initiated during CPR; to investigate the effects of dual dispatch of 
fire-fighters and EMS on short- and long-term survival; to explore regional differences in response times and 
survival rates in relation to dual dispatch of fire-fighters and EMS in cases of OHCA.  
Methods and results: 
Study I. Observational study of 34,125 patients. From 1992 to 2005, bystander CPR significantly increased, 
especially when performed by laypersons, in witnessed (40% to 55%, p<0.0001) and unwitnessed (22% to 
44%, p<0.0001) OHCA. Bystander CPR was associated with higher ventricular fibrillation (VF) rates 
(adjusted OR 1.73, 95% CI 1.62–1.86) and improved 30-day survival (adj. OR 2.20, 95% CI 1.68–2.90). 
Study II. Randomised trial concerning 200 cases of witnessed OHCA. Trans-nasal evaporative cooling was 
feasible in pre-hospital arrests. Eighteen device-related adverse events were reported, where one case of 
epistaxis was defined as serious. Time to target temperature of 34°C was shorter in the treatment group for 
both tympanic (102 vs. 282 minutes, p=0.03) and core (155 vs. 284 minutes, p=0.13) temperature. 
Study III. Intervention study (trained fire-fighters dispatched in cases of OHCA) using historical controls. 
When dispatched, fire-fighters were first on the scene and connected an automated external defibrillator 
(AED) in 41% of the cases. Thirty-day survival improved from 3.9% (control) to 7.6 % (intervention) 
(p=0.001, adjusted OR 2.8, 95% CI 1.6–4.9). Survival to 3 years increased from 2.4% to 6.5% respectively 
(p<0.001, adjusted OR 3.8, 95% CI 1.9–7.6). 
Study IV. Intervention study using historical controls, assessing the regional impact of Study III in areas 
with different population densities. Median response times shortened significantly in all subgroups, ranging 
from 0.8 (downtown) to 3.2 minutes (rural). The effect on 30-day survival rates varied depending on 
population density, with the lowest impact in rural areas 
Conclusions:  
Bystander CPR, especially when performed by laypersons, increased in Sweden between 1992 and 2005 and 
is associated with increased VF and survival rates. Intra-arrest trans-nasal cooling in cases of OHCA is safe 
and feasible and it shortened the time interval required to cool patients. Implementation of a dual dispatch 
system (fire-fighters and EMS) in cases of OHCA was associated with increased 30-day- and 3-year 
survival. Shortened response times were seen in sparsely as well as in highly populated regions. The lowest 
impact of a dual dispatch system on survival was seen in rural areas.  
Key words: out-of-hospital cardiac arrest, EMS, first responder, CPR, automated external defibrillators, 
hypothermia, intra-arrest cooling. 
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1 RATIONALE  
Despite some advances in recent years, survival rates of patients suffering out-of-hospital cardiac 
arrest (OHCA) are poor. Several knowledge gaps remain that need to be addressed by way of 
pre-hospital intervention studies.   
After the introduction of a dual dispatch system in the greater Stockholm area, using fire-fighters 
as first responders in cases of OHCA, a pilot study showed promising results (reduced response 
times and improved survival) in different subpopulations.1 Furthermore, when analysing the 
results of the pilot study, several new issues were raised. In the current work some of these issues 
were addressed, including how the benefits of dual dispatch in cases of OHCA would remain 
over time; what effect would in-hospital factors have on survival rates during the years of the 
intervention; and, where does intervention with dual dispatch have the most effect from a 
regional perspective? 
In addition to the above, this work covers the largest randomised controlled trial concerning the 
effects of intra-arrest cooling in cases of OHCA, where hypothermia treatment is induced during 
cardiopulmonary resuscitation. A new method for induction of hypothermia, trans-nasal 
evaporative cooling via the nasal cavity, which may be applied during resuscitation, was studied 
as regards safety, feasibility and cooling efficacy.  
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2 INTRODUCTION  
 “Cardiac arrest is the cessation of cardiac mechanical activity as confirmed by the absence of 
signs of circulation.”  
(Jacobs et al, Updated Utstein definition2) 
 
2.1 HISTORICAL GLANCE 
Closed chest massage similar to the standardised chest compression used today was described 
as early as 1904 in anecdotal case reports. In 1958 colleagues Kouwenhoven, Knickerbocker 
and Jude made a pioneering discovery. While performing defibrillation studies on dogs, they 
accidentally discovered that a femoral artery pulse could be achieved by forcefully applying 
the defibrillation paddles to the chest. Subsequently, they moved further in their experimental 
setting and assessed where to press on the chest, how rapidly and to what depth to obtain a 
maximal haemodynamic effect. Shortly thereafter Jude applied this technique of closed-chest 
cardiac massage when treating a patient with cardiac arrest following anaesthesia, which 
resulted in successful outcome and complete recovery. In 1960, in a landmark study, the three 
investigators reported findings (in the Journal of the American Medical Association) 
concerning 20 cases of in-hospital cardiac arrest, where 14 patients survived.3  
In parallel, Peter Safar developed a technique for airway management by tilting the back of the 
head and thereafter applying mouth-to-mouth breathing.4 The formal connection of chest 
compression with mouth-to-mouth ventilation to create cardiopulmonary resuscitation (CPR) 
occurred when Safar, Jude, and Kouwenhoven presented their findings at the annual Maryland 
Medical Society meeting on September 16, 1960 in Ocean City.5 Somewhat earlier, a landmark 
study was published in 1956 by Zoll, who described 4 cases in which ventricular fibrillation 
(VF) was terminated 11 times by externally applied electric countershocks.6 In 1962 the use of 
direct-current monophasic waveform defibrillation was described,7 and in 1966 the American 
Heart Association developed their first CPR guidelines. 
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2.2 EPIDEMIOLOGY  
Out-of-hospital cardiac arrest (OHCA) is a major public health concern,8 accountable for more 
than 60% of deaths from coronary heart disease.9 The incidence of OHCA and its outcome vary 
substantially between countries and also within different regions in a nation.10-13 In Europe, the 
incidence of OHCA (any rhythm) where the emergency medical services (EMS) have initiated 
resuscitation attempts is estimated to be 38 per 100,000 person-years, ranging from 17 to 53 per 
100,000 depending on the setting. This translates into almost 300,000 victims annually in 
Europe.14 In 2006 the corresponding incidence of EMS-treated OHCA in the US was estimated 
to be 55 per 100,000 person-years.15 Recently, the number of persons affected by OHCA in the 
US was estimated to be around 382,000 annually.16  
The incidence of OHCA with ventricular fibrillation (VF) as first rhythm has been estimated to 
be 17 per 100,000 person-years in Europe and 21 per 100,000 person-years in the US.14, 15 In 
Sweden the incidence of EMS-treated OHCA varies between counties, ranging from 37 to 67 per 
100,000 person-years.17 In Stockholm County the incidence reported in the register is 46 per 
100,000 person-years. 
 
2.2.1 Survival rates 
In two epidemiological studies the overall outcome in cases of EMS-treated OHCA of any 
rhythm, measured as OHCA to hospital discharge, has been estimated to be 10.7% in Europe and 
8.4% in the US.14, 15 Survival rates in EMS-treated OHCA with VF as first rhythm were 
approximated to 21.2% and 22.0% respectively. In Sweden, recent data from the Swedish 
Cardiac Arrest Register (SCAR) show 30-day survival rates of 10.4% (all rhythms) and 31% for 
patients with VF as first rhythm.17  
 
2.2.2 Populations at risk 
Some patient categories are identified as populations at risk of cardiac arrest (e.g. those with 
ischaemic heart disease, dilated or hypertrophic cardiomyopathy, severe heart failure, previous 
cardiac arrest and arrhythmia risk markers).18 In these identified populations the incidence of VF 
is many times greater than in the general population, which make them suitable for preventive 
measures with an implantable cardiac defibrillator. However, the vast majority of cases of cardiac 
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arrest occur in the general population without any known cardiac disease, which makes them 
difficult to predict and prevent.18 In approximately 50% of patients with ischaemic heart 
disease, OHCA is the first recognized cardiac event.19 Within hospitals various systems have 
been developed to recognize patients at risk of cardiac arrest and, subsequently, take preventive 
measures.20, 21 In OHCA some genetically predisposed individuals may be identified by their 
family histories or by genetic tests. However, to find tools to identify the main populations at risk 
of OHCA remains a challenge.  
 
2.3 PROGNOSTIC FACTORS IN CARDIAC ARREST  
Although several of the presented predictors for survival are interdependent many of them still 
reflect the association between the time to effective treatment (CPR and defibrillation) and 
survival. The importance of time to treatment will be discussed in the next section.  
 
2.3.1 Causes of cardiac arrest 
In 1991 a consensus of opinion concerning uniform reporting in cases of cardiac arrest was 
achieved. This is referred to as the Utstein template, which was designed to facilitate comparison 
of results from different cardiac arrest studies.22 A cardiac aetiology, mainly due to coronary 
artery disease,9, 23 is the most common cause of OHCA and is associated with a better prognosis 
compared with OHCA due to non-cardiac causes.24, 25 However, the cause of OHCA is usually 
presumed by the EMS crew or the emergency physician, often with limited information on the 
patients and the circumstances of the arrest. This may affect the accuracy of reporting. The 
Utstein definition states that an arrest is presumed to be of cardiac aetiology unless it is known 
or likely to have been caused by trauma, submersion, drug overdose, asphyxia, exsanguination, 
or any other non-cardiac cause as best determined by rescuers.2 When comparing the 
assumptions of emergency physicians with retrospective analyses of clinical records and 
autopsy reports, Kürkciyan et al. demonstrated that cardiac origin is most common (69% of 
cases). These assumptions of cardiac aetiology showed a sensitivity of 95% and a specificity of 
77%.26 Pulmonary embolism, a ruptured aortic aneurysm, and intracerebral haemorrhage were 
frequent in patients where the assumptions of cardiac origin were incorrect. Similar findings 
have been reported by others.24, 27 The various causes of OHCA are presented in Table 1.  
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Table 1. Causes of OHCA divided into cardiac and non-cardiac origin.  
 
Adapted from Hollenberg et al., 201328 
 
2.3.2 Location of cardiac arrest 
The specific location where a cardiac arrest occurred or the patient was found is most often 
divided into place of residence, public place, or other.2 Most investigators report that around 
two thirds of cases of OHCA occur at the patient’s home.29, 30 In one observational study, OHCA 
outside home was associated with a threefold greater chance of survival compared with when the 
collapse occurred at home.30 This may depend on several factors such as advanced age, 
comorbidity, more often unwitnessed arrest and lower frequency of bystander CPR compared 
with OHCA that occurred in a public place.30 On the other hand, OHCAs occurring in a public 
place are independently associated with improved survival 31 and are associated with a greater 
incidence of VF compared with OHCAs occurring at home.29 In addition, OHCAs occurring in 
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public locations such as airports, sport facilities and malls increasingly are subjects of public 
access defibrillation (PAD), which has been shown to improve survival rates in these particular 
settings.32, 33 
 
2.3.3 Witnessed cardiac arrests 
A witnessed CA is defined as a CA seen or heard by another person or an arrest where the 
heart rhythm is monitored. Witnessed collapse, in contrast to unwitnessed collapse, has been 
shown to be an independent predictor of an increased chance of survival in OHCA.34, 35 
Witnessed OHCA is seen in about two-thirds of cases and is associated with a greater 
proportion of patients receiving bystander CPR and a higher VF incidence compared with 
unwitnessed OHCA.35 A witnessed OHCA is associated with two- to threefold better survival 
than an unwitnessed arrest.1, 34, 36 In many studies cases of unwitnessed OHCA are not included 
because of the extremely low chance of survival of these patients. 
 
2.3.4 Age 
Advanced age is associated with worse outcome in cases of OHCA.37 The characteristics vary 
somewhat within different age groups and greater age is associated with a lower rate of 
bystander CPR, less VF as first rhythm and fewer cases with cardiac aetiology.37 However, VF 
as first rhythm compared with other initial rhythms is associated with increased survival 
despite age.  
 
2.3.5 First rhythm 
“First rhythm” refers to the first rhythm recorded by a monitor or when a defibrillator is 
attached to a patient after cardiac arrest.2 It may be defined as either shockable (i.e. ventricular 
fibrillation (VF) or pulseless ventricular tachycardia (VT)) or non-shockable (pulseless 
electrical activity (PEA) or asystole).  
These initial rhythms indicate different pathophysiological mechanisms. VF may occur as a direct 
effect of an acute ischemic episode or as a consequence of a previous ischemic event such as 
myocardial infarction. The ischemic zones trigger re-entry circuits, which may induce an electric 
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chaos that make the myocardium to contract in an unsynchronised way (i.e. fibrillate).38 Asystole 
is associated with the cessation of electric activity in the myocardium. It is associated with 
prolonged cardiac arrest and thus poor prognosis. It may be subsequent to VF or due to non-
cardiac causes of the CA. In PEA the contractility of the heart is lost but with maintained electric 
activity. It is associated with non-cardiac causes of CA such as hypovolemia and pulmonary 
embolism. 
In several studies VF or VT as first monitored rhythm has been demonstrated to be the 
strongest independent predictor of survival in OHCA.34, 39-41 The proportion of cases of VF/VT 
as first rhythm has been assessed in several studies to be about 25–50%, but it has declined 
over the last few years.15, 42, 43 There is a strong relationship between first rhythm and the time 
interval from collapse until the rhythm is recorded by the EMS. Thus, when the rhythm is 
assessed very soon after the arrest the rate of VF may be substantially higher, as fewer patients 
have deteriorated to asystole.39 In studies assessing public access defibrillation in OHCA 
before arrival of the EMS, the VF rate has been reported to be as high as 50 to 65%. 33, 44, 45 
 
2.3.6 Gender 
About a third of cases of OHCA are in women.46, 47 The characteristics differ somewhat from 
those in men, as women are affected at a greater age. In women, OHCA more often occurs at 
home; they receive a lower rate of bystander CPR and show a lower VF rate compared with 
men. In some studies, when adjusting for the differences in characteristics between men and 
women, female sex has been associated with improved survival.46-48  
 
2.4 TREATMENT STRATEGIES IN CARDIAC ARREST 
The principles of treatment in OHCA follow the different links in the chain-of-survival concept, 
where emphasis is placed on minimizing the time to treatment (see Figure 2).49 The five links of 
the chain-of-survival are: Early access; Early CPR; Early Defibrillation; Early Advanced Life 
Support (ALS); and Early Post-Resuscitation Care.  
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Figure 2. Chain-of-Survival. 
 
2.4.1 Early Access 
The first link in the chain emphasizes the importance of early recognition and recruitment of 
resources to the scene of the arrest by way of an emergency call. At the other end of the line it is 
important for the dispatcher receiving the emergency call to rapidly identify the condition, to 
locate the place of the event and to minimize the time delay at the emergency dispatch centre.50, 51 
When the condition is identified promptly by the dispatcher, this is associated with significantly 
shorter response time intervals and increased survival rates.52 Strategies have been developed to 
improve the dispatchers’ skills, which have reduced the time for identification and dispatching.53 
The role of the dispatcher also includes guidance in telephone-CPR to untrained bystanders.54  
 
2.4.2 Early cardiopulmonary resuscitation 
The second link refers to the importance of early bystander CPR. Current guidelines recommend 
a chest compression:ventilation ratio of 30:2 with a compression rate of 100 per minute at a depth 
of at least 5 cm in adults.55 The chest should be allowed to expand before initiating the next 
compression. High-quality chest compression may result in cerebral and coronary perfusion of 
about 30% of normal blood flow.56 Continuous CPR builds up diastolic pressure, which is 
necessary to increase coronary perfusion pressure and it has been suggested that a coronary 
perfusion pressure over 15 mmHg is needed to achieve return of spontaneous circulation (ROSC) 
in cases of OHCA.57  
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Cardiopulmonary resuscitation may also extend the time of VF before deterioration to asystole, 
thus working as a bridge to defibrillation.58 In addition, VF amplitude when CPR is performed 
has been shown to be associated with the likelihood of success in defibrillation.59  
Bystander CPR is an independent predictor of survival in cases of OHCA and immediate CPR 
may substantially improve survival rates in OHCA with VF as first rhythm.60-62 However, the 
role of ventilation has been debated and in observational studies compression-only CPR has been 
associated with an outcome comparable with that in standard CPR.63, 64 Recently, in two 
randomised trials in which telephone-assisted CPR carried out by untrained laypersons was 
assessed, it was shown that the effect of compression-only CPR was similar to that of standard 
CPR.65, 66 Guidelines from the American Heart Association recommend that laypersons with no 
CPR training should perform compression-only CPR until EMS providers or other responders 
take over care of the victim.67  
The clinical effect of mechanical devices for CPR has been debated. Although haemodynamics 
may be improved in experimental models,68, 69 so far no outcome benefit has been demonstrated 
in randomised clinical trials.70 One previous randomised clinical trial was disrupted because the 
use of an automated CPR device was associated with worse neurological outcome at discharge 
compared with standard manual CPR.71 Mechanical CPR may be advantageous in prolonged 
resuscitation such as in cases with accidental hypothermia, intoxication, thrombolysis in 
pulmonary embolism, or during patient transport.  
 
2.4.3 Early defibrillation 
The third link is early defibrillation, a therapy that is limited to OHCAs with VF/VT as first 
rhythm and to those cases that convert to VF/VT from an initial non-shockable rhythm during 
resuscitation. A first rhythm of VF is one of the strongest independent predictors of survival in 
OHCA.34 When defibrillation can be performed in patients with VF within minutes after collapse, 
the survival rate may well be over 50%. In one study, when security officers defibrillated VF 
arrests within 3 minutes of collapse, the survival rate was 74%.72 The association between time 
interval and survival in this group of patients cannot be underrated. Predictive models for 
survival in witnessed OHCA with VF as first rhythm have shown that the probability of survival 
to hospital discharge decreases by about 10% per minute without CPR or defibrillation.60  
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2.4.3.1 First responders and public access defibrillation 
First responders are persons who are certified to provide medical care in emergencies before 
more highly trained medical personnel arrive on the scene. In cases of OHCA, fire-fighters, 
police and security officers trained in CPR and automated external defibrillator (AED) use have 
been used as first responders. In several trials the use of first responders has resulted in success in 
shortening response times when they are dispatched in cases of suspected OHCA. 45, 73-76 In some 
studies, these interventions have been associated with increased survival rates in patients 
presenting with VF or VT.1, 73 Few studies, however, have shown an impact of such intervention 
in cases of cardiac arrest with any first rhythm.77  
Public access defibrillation is a strategy to enable defibrillation with the minimum delay, 
before the arrival of the EMS. Public access defibrillation programmes have been shown to 
improve survival rates in subgroups of patients with VF as first rhythm in different settings, 
often in limited geographical areas or situations.33, 78, 79 Recently, a Japanese study showed a 
more than twofold increase in survival with good neurological outcome in patients with 
ventricular fibrillation as first rhythm who had been defibrillated with a public AED by 
laypersons.32  
 
2.4.4 Early advanced life support 
The fourth link is early ALS, meaning advanced airway management and use of intravenous 
drugs. Despite the recommendation in current guidelines, the use of adrenaline in cases of OHCA 
is under debate. It has repeatedly been associated with increased return of spontaneous circulation 
(ROSC) rates, but without improvements in overall survival rates.80-82 In a randomised trial, 
Olasvengeen and colleagues tested the use of any intravenous drug versus no intravenous drugs 
and came up with similar findings.83 Amiodarone is recommended in refractory VF and in a 
randomised trial (compared with placebo) significantly increased survival to hospital 
admission,84 and when compared with lidocaine, increased survival to discharge.85  
The use of advanced airway management in OHCA is controversial. Although probably needed 
in some cases, advanced airway techniques (i.e. endotracheal intubation or use of a supraglottic 
device) have in large observational studies been associated with worsened neurological outcome 
and decreased survival compared with bag-mask ventilation.86, 87 On-going studies will add 
valuable information to this issue. 
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In one landmark US multicentre study the addition of ALS to a previously optimized EMS 
system with rapid defibrillation did not improve the rate of survival after out-of-hospital 
cardiac arrest.80 In summary, intravenous drug administration and advanced airway management 
are included in ALS intervention, but are not prioritised compared with early defibrillation and 
uninterrupted CPR.  
 
2.4.5 Early post-resuscitation care 
The fifth link includes the in-hospital management of resuscitated patients (i.e. post-resuscitation 
care). Recently, a statement document from the ERC and the AHA defines the condition as post-
cardiac arrest syndrome.88 Although the treatment with therapeutic hypothermia has received 
most attention in recent years, a more comprehensive approached with combined interventions 
has been emphasised to improve the in-hospital management of these patients.89  
 
2.4.5.1 Therapeutic hypothermia 
Cooling of the human body decreases the cerebral metabolic rate for oxygen by about 6% per 
1°C reduction in body core temperature.90 In cardiac surgery deep hypothermia is routinely used 
for cerebral protection.90, 91 Both experimental and clinical data indicate that mild hypothermia is 
neuroprotective after a period of global cerebral hypoxia-ischemia.92, 93  
In two randomised trials with 273 and 77 unconscious patients resuscitated from a witnessed VF 
arrest, therapeutic hypothermia improved neurological function among survivors. In these studies 
patients were cooled to 33 °C for 12 to 24 hours and actively94 or passively95 re-warmed to 
normal body temperature. The primary outcome measure was survival with good neurological 
outcome. The cerebral performance category (CPC) was assessed, where CPC 1 and CPC 2 are 
considered as good neurological outcome and CPC 3 to 5 as bad (Table 2). These studies 
represent the scientific basis for international recommendations concerning therapeutic 
hypothermia, which is an established method at intensive care units for this subgroup of patients 
(i.e. witnessed OHCA with VF/VT as first rhythm). Recently, Nielsen et al., in a randomised trial 
including 950 patients, compared the temperatures of 33 °C and 36 °C for 24 hours in post-
cardiac arrest patients independently of the first rhythm (excluded were unwitnessed arrests with 
asystole as first rhythm). No differences in survival or neurological outcome were found.96 The 
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clinical implications of this study have not yet been seen.  
While clinical data is mainly derived from hospital cooling, started hours after collapse (eg. 
Nielsen et al, HACA, Bernard et al.),94-96 most of the experimental data support the initiation of 
cooling very early, either during CPR (i.e. intra-arrest)97 or after restoration of circulation (i.e. 
post-ROSC).98 Despite the lack of conclusive clinical data, guidelines recommend starting 
cooling as early as possible. Two randomised trials concerning post-ROSC cooling with cold 
fluids compared with hospital systemic cooling showed no differences in survival rates or 
neurological function.99, 100 In one study the use of large amounts of cold intravenous fluids was 
associated with severe haemodynamic side-effects, including a significantly increased number of 
cases of re-arrest.100 Intra-arrest cooling in cases of OHCA has been tested in safety and 
feasibility trials with cold fluids.101, 102 In animal studies, trans-nasal evaporative cooling has been 
shown to cool the brain primarily and thereafter the whole body. The method is described in 
detail below (Methods).  
Table 2. Cerebral performance categories.103 
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2.4.5.2 Coronary angiography/revascularization  
Although supported by a low level of evidence, current guidelines recommend immediate 
coronary angiography in resuscitated OHCA patients with (electrocardiographic) ST-segment 
elevation myocardial infarction (STEMI).55 However, as ECG findings in OHCA patients are 
poor predictors of coronary occlusion,104 it is recommended that immediate coronary 
angiography should be considered in all post-cardiac arrest patients with suspected coronary 
artery disease.55 Several observational studies have demonstrated as association between 
immediate angiography and increased survival.105, 106 However, at present there is no data from 
randomised clinical trials.  
 
2.4.5.3 Other post-cardiac arrest parameters 
Some in-hospital factors have been associated with poor outcome, such as fever, high blood 
glucose levels, elevated serum potassium, acidosis, seizures, advanced age and long delay to 
ROSC.107, 108 Although there is a lack of good evidence to support intensive care measures, 
there are some studies where structured programmes89 or forms of combined intervention109 
have been implemented to improve the intensive care of post-cardiac arrest patients, which 
have been shown to improve survival compared with historical controls. The recommendations 
made by the European Resuscitation Council (ERC) concerning certain parameters are 
presented in Table 3.55   
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Table 3. In-hospital factors/interventions that are recommended in ERC guidelines 2010.55 
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3 AIMS 
The overall aim of the present work was to explore ways towards improved management of 
victims of OHCA. The studies embrace several aspects of treatment of cardiac-arrest patients 
such as the importance of bystander CPR, early defibrillation and early hypothermia. The 
emphasis was to assess the clinical effect of interventions carried out to improve CPR and early 
defibrillation by using non-health personnel as first responders in cardiac arrests in the context of 
pre-hospital care.  
 
3.1 SPECIFIC AIMS 
To describe changes in the proportion of bystanders performing cardiopulmonary resuscitation 
in cases of OHCA in Sweden, and to study the impact of bystander CPR on ventricular 
fibrillation and on survival over various time periods.  
To determine the safety, feasibility and cooling efficacy of pre-hospital trans-nasal evaporative 
cooling in humans, and to explore the effects on neurologically intact survival to hospital 
discharge. 
To determine the impact of a dual dispatch system (using fire-fighters as first responders) on 
short- and long-term survival in cases of OHCA, and to investigate potential differences 
regarding in-hospital factors and forms of intervention between patient groups.  
To determine the effects on response times and 30-day survival in relation to population density 
after the implementation of a dual dispatch system in cases of OHCA. 
 




The Regional Ethics Committee approved all studies in this work. Ethical considerations for 
treating subjects without their express consent were in accordance with the Helsinki 
Declaration of 1964, revised in 2008. In Study II, informed consent was obtained from all 
patients, or, in cases where the patient died, the next of kin or a legal representative.  
 
4.2 PATIENTS 
As presented in Table 4, the patients in the four studies were: OHCA patients in Sweden, 1992–
2005 (Study I); witnessed OHCA patients from 15 European study sites, November 2008–June 
2009 (Study II); OHCA patients in Stockholm, 2004–2009 (Studies III & IV).  
Table 4. Characteristics of each study population. 
 
*DNAR = do not attempt resuscitation 
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4.3 THE SWEDISH CARDIAC ARREST REGISTER 
All data for Study I and most of the data for Studies III and IV were collected from The Swedish 
Cardiac Arrest Register. It is a national register funded by the Swedish National Board of Health 
and Welfare. The register started in 1990 and is at present run by the Swedish Resuscitation 
Council. The register depends on voluntary participation by the EMS districts in Sweden and 
coverage has increased gradually from a few EMS districts in 1990 to include all districts in 
2009. The EMS crews report according to the Utstein model. For each case the EMS crew 
complete a digital form with data on the arrest based on clinical findings and bystander 
information, such as: demographic information; estimated time of arrest; presumed aetiology 
divided into different categories (see Table 1); whether the OHCA was witnessed or not; type 
of resuscitation procedure and interventions; information on whether CPR was performed and 
which type of bystander was performing CPR (i.e. layperson, ambulance crew, police, 
healthcare providers or others). The first recorded rhythm is defined as VF, PEA or asystole. 
When AEDs have been used, the rhythms are defined as shockable (i.e. VF/VT) or non-
shockable. Data on 30-day survival is completed by the rapporteur from each EMS district 
who monitors the outcome of the patients by merging data with the National Register of 
Deaths.    
 
4.4 OBSERVATIONAL STUDY (STUDY I) 
Study I was an observational study based on OHCA patients included in the Swedish Cardiac 
Arrest Register. The study period was from the 1st of January 1992 to the 31st of December 
2005. Temporal trends of patient and baseline characteristics were assessed, as were comparisons 
between patients in the early period of the study (i.e. 1992–1995) versus the late period (i.e. 
2002–2005). 
 
4.5 RANDOMISED CLINICAL TRIAL (STUDY II) 
Study II was designed as a prospective randomised trial conducted by EMS in 15 sites in five 
European countries between November 2008 and June 2009. 
The randomization procedure was as follows: EMS personnel screened patients and the 
randomisation envelope was opened if the patient appeared to be eligible. The patient was 
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assigned to either intra-arrest trans-nasal evaporative cooling or to no pre-hospital cooling. 
Trans-nasal cooling was intended to continue until systemic cooling was started in the hospital. 
Patients in both groups were cooled in the hospital according to institutional standards. The 
EMS crew completed the case report forms as regards pre-hospital data for each case. In 
general, the attending physician at the intensive care unit collected in-hospital data, including 
outcome data on survival to discharge. Neurological assessment at discharge was intended to 
be performed by physicians blinded to the treatment given. 
 
4.5.1 Method of trans-nasal evaporative cooling 
Trans-nasal evaporative cooling is a method used for early, non-invasive induction of 
hypothermia. The method was developed primarily to cool the brain and in animal studies has 
been shown to create a temperature gradient in which the brain is cooled faster than the rest of 
the body.110, 111 In addition, in animal studies the method has also been associated with 
improved ROSC rate,112 improved coronary perfusion pressure during resuscitation,113 and 
improved outcome in terms of survival and neurological function.110 In clinical trials it has 
been proven to be safe to use in-hospital, in cardiac-arrest patients with ROSC, when cooling 
was started at the emergency department.114 In this study of post-ROSC cooling the 
temperature decreased by 2.3 °C per hour. 
 The device used for trans-nasal evaporative cooling (RhinoChill) consists of a backpack that 
weighs 12 kg containing a disposable nasal catheter, a control unit, a 2-litre bottle of coolant, 
and an oxygen tank. First, the nasal catheters are inserted through the nostrils. Second, a 
mixture of oxygen (or air) and an inert liquid coolant (perfluorohexane), via the nasal catheter, 
are sprayed into the upper surface of the nasal cavity. There the coolant evaporates and absorbs 
heat from the tissues, thereby cooling them and the innate vasculature that supplies blood to 
the brain.  
The tubing set is connected to a battery-operated control unit that allows the cooling rate to be 
controlled by adjusting the oxygen/air flow rate. The device is automatically switched off if the 
pressure in the nasal cavity exceeds 60 cm H2O. This system delivers trans-nasal evaporative 
cooling for 22.5 minutes at an oxygen/air flow rate of 40 L/min. Additional oxygen tanks or a 
connection to an ambulance or hospital oxygen supply are required for longer use. The 2-L 
bottle contains enough coolant for 1 hour of cooling. The equipment is easy to handle and the 
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device can most often be applied to the patient and be ready to use within one minute. 
 
4.6 INTERVENTION WITH HISTORICAL CONTROLS (STUDIES III, IV) 
Studies III and IV were performed in Stockholm County between the 1st of January 2004 to the 
31st of December 2009. On Dec. the 31st 2009 Stockholm County had a population of 2,019,182 
inhabitants, of which 50.6% were female and 14.7% persons over 65 years of age.115  
Study III is the main study of the SALSA project (Saving Lives in Stockholm Area). It was 
designed as a prospective, interventional trial with historical controls, conducted by the EMS and 
the Fire Department in Stockholm County.  
Study IV had the same study population as in Study III and it was designed to assess the regional 
effects of the intervention. However, in Study IV, cases where the exact geographical coordinates 
for the arrest could not be found were excluded (3% of all cases). The patients were divided into 
four subgroups depending on the population density of the place of arrest. Cut-off values for 
population densities were decided after reviewing previous studies,116 combined with context-
specific factors. The groups were classified as: 1. Rural (<250/km2), 2. Suburban (250–
2999/km2), 3. Urban (3000–5999/km2) and 4. Downtown (≥6000/km2). 
 
4.6.1 Emergency Medical Services in Stockholm. 
The EMS system in Stockholm is two-tiered in emergencies such as OHCA, with an advanced 
life-support level as the second tier (e.g. nurses specialized in anaesthesia, or an 
anaesthesiologist). During the study period of 2004–2009 the number of ambulances was the 
same. In 2004 there were four ALS vehicles manned by nurses specialized in anaesthesia. In 
2007, this was changed to two ALS vehicles manned by specialised nurses and one ALS vehicle 
manned by anaesthesiologists. 
 
4.6.2 Dual dispatch of first responders 
During 2005, all 43 fire stations in Stockholm County were gradually equipped with AEDs as 
part of the SALSA project, with the main objective of shortening response times and thereby 
increasing survival in cases of OHCA. All fire-fighters underwent an 8-hour course in CPR and 
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use of an AED according to ERC guidelines.55 For all fire-fighters, the training programme was 
repeated once a year during the study period. 
Dual dispatch of EMS and fire-fighters occurred in cases where the dispatcher suspected an 
OHCA. Subsequently, the dispatcher alerted the nearest available EMS and thereafter deployed 
the closest available fire department by using a computer-mediated alarm code.  
In cases of OHCA where the fire brigade arrived first, the fire-fighters were responsible for 
performing the medical assessment. If the patient was unresponsive and pulseless, CPR was 
started and the AED was attached to the patient. Ventilation by fire-fighters was performed with 
a mouth-to-mouth resuscitation mask. When the EMS crew arrived, they took over responsibility 
for the treatment.  
 
4.6.3 Data collection  
In addition to the data from the Swedish Cardiac Arrest Register in Study III, several other data 
sources were used to collect additional information. Event times, such as when a call was made 
to a dispatch centre, dispatch and arrival of first responders and additional dispatch information 
were collected from the emergency dispatch centre. Data on co-morbidity was derived from 
registries within the National Board of Health and Welfare. Data on in-hospital measures such 
as therapeutic hypothermia, cardiac interventions such as angiography and percutaneous 
coronary intervention were collected from medical records, the Swedish Register of Intensive 
Care, and Swedeheart.117, 118 
The geographical data of the OHCAs in Study IV was collected by means of a geographic 
information system (GIS), which is a computer-based method to integrate and analyse 
geographical data. A parish is the smallest administrative level for which they have shapefiles in 
Sweden. In Study IV, the digital spatial data (x and y coordinates of the OHCA) obtained from 
the emergency dispatch centre was used to locate the parish in which each OHCA had occurred. 
Subsequently, the cardiac arrest data was merged with the spatial data so as to be able to 
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4.7 STATISTICAL METHODS 
A summary of the statistical methods used is presented in Table 5. For details, see the sections on 
statistical analysis in the separate studies.  









5.1 BYSTANDER CPR IN SWEDEN – STUDY I 
In total, 34,125 patients were included in the analysis. There were no differences in patient 
baseline characteristics between the different ambulance organisations in regard to age, sex, 
proportion of patients who received bystander CPR and place of cardiac arrest. 
 
5.1.1 Main results  
There was a significant increase in the proportion of patients who received bystander CPR 
among witnessed as well as non-witnessed cases (Figure 3). There was a significant increase in 
bystander CPR performed by laypersons (21% in 1992 vs. 40% in 2005; p < 0.0001) but no 
change as regards healthcare providers, ambulance personnel or police (Figure 4). 
Bystander CPR was associated with an increased number of patients found in shockable rhythm, 
compared with no bystander CPR (odds ratio (OR) 1.73; 95% confidence interval (CI) 1.62–1.86; 
n=14,294). Bystander CPR was associated with increased survival both in the early study period, 
1992–95 (OR 2.11; 95% CI 1.64–2.72) and later, 2002–2005 (OR 2.20; 95% CI 1.68–2.90).  
Figure 3. Change in bystander CPR rates in witnessed and non-witnessed cases  
during the study period (1992–2005). 
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5.2 INTRA-ARREST COOLING – STUDY II 
The study period for this randomised safety and feasibility trial was November 2008 to June 
2009. Out of 200 enrolments, six patients (three from the treatment group and three control 
subjects) had missing outcome data. One hundred and ninety-four patients, therefore, were 
included in the intention-to-treat analysis (93 intervention cases vs. 101 controls). The patient 
groups showed similar demographics, initial rhythms, bystander CPR rates, and intervals to 
CPR and arrival of ALS personnel.  
 
5.2.1 Main results 
5.2.1.1 Safety 
Eighteen device-related adverse events were recorded in the intervention group (one case of 
periorbital emphysema, three of epistaxis, one of perioral bleeding and 13 cases of nasal 
discoloration; see Table 6). The nasal discoloration resolved spontaneously in all five 
resuscitated patients. One case of epistaxis was defined as serious (in a patient with an 
underlying coagulopathy). This was the only device-related serious adverse event. The total 
numbers of serious adverse events not related to the cooling device that occurred within seven 
days were seven in the treatment group and 14 in the control group. 
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Table 6. Adverse events in Study II. 
 
*One serious device-related case of epistaxis in a patient with coagulopathy. 
 
5.2.1.2 Cooling efficacy 
The median time to the start of intra-arrest cooling in the treatment group was 23 minutes. On 
arrival at the hospital, the mean tympanic temperature was significantly lower in the treatment 
group (34.2 °C versus 35.5 °C, p=0.001). The median time from the arrest to target 
temperature (tympanic; < 34 °C) was 102 minutes in the treatment group compared with 291 
minutes in control patients (p=0.03; Figure 5). The median time to target temperature (core; 
<34 °C) in the treatment group was 155 minutes versus 284 minutes in the controls (p=0.13). 
Figure 5. Time to target temperature (core) of <34°C  
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5.2.1.3 Outcome 
Outcome data on survival to hospital discharge, and survival to discharge with good neurological 
function, defined as CPC 1–2, concerning the entire group, those who received rescuer CPR 
within 10 minutes, and those with a presenting rhythm of VF are presented in Table 7.  
Table 7. Survival to discharge and neurologically intact survival to discharge (CPC 1-2) 
.  
 
5.3 DUAL DISPATCH OF FIRST RESPONDERS IN OHCA – STUDY III 
The period for Study III was the 1st of January 2004 to the 31st of December 2009. In total, 2,581 
OHCA patients were included, of which 620 were in the historical control group (2004), and 
1,961 were in the intervention group (2006-2009). Baseline characteristics were similar except 
for the proportion of cases of witnessed OHCA, which was significantly greater in the control 
group than in the intervention group. 
 
5.3.1 Main results 
5.3.1.1 EMS and first responders 
When dispatched, fire-fighters were first on the scene and connected an AED in 41% of the 
cases. Even if not first on the scene, they assisted the EMS and performed CPR in 90% of all 
patients. 
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The median time interval to treatment (i.e. dispatch to arrival of EMS or fire-fighters) was 
significantly shorter in the intervention group than in the control group (6.7 minutes vs. 7.7 
minutes, p<0.001). 
In the intervention group, the proportion of patients with VF/VT was significantly greater than in 
the control group (25% vs. 20%, p=0.02). 
 
5.3.1.2 Short- and long-term outcome 
Thirty-day survival improved from 3.9% in the control group to 7.6% in the intervention group 
(adjusted OR 2.8, 95% CI 1.6–4.9, p=0.001). Survival to 3 years increased from 2.4% to 6.5% 
respectively (adjusted OR 3.8, 95% CI 1.9–7.6, p<0.001). As shown in Figure 6, among 
witnessed cases the rates of ROSC, admission alive, 30-day survival and 3-year survival were 
significantly greater in the intervention group than in the controls.  
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5.3.1.3 In-hospital factors 
For the subgroup of VF/VT patients, the proportions of patients treated by means of therapeutic 
hypothermia were similar in the two groups (62% vs. 71%, p=0.35).  
Among patients with ST-elevation myocardial infarction (STEMI) there was a significant 
difference between the control group and the intervention group in the proportion of patients who 
underwent immediate catheterization (39% vs. 69% respectively, p=0.03). However, no 
difference between groups was found in STEMI patients who underwent immediate reperfusion 
measures (i.e. acute catheterization or thrombolysis) (69% vs. 72%, p=0.82). There was a 
significant difference between the control and the intervention group in patients where 
angiography was performed during their hospital stay (13% vs. 27% respectively, p=0.001).  
 
5.4 REGIONAL DIFFERENCES IN CASES OF OHCA - STUDY IV 
The study period was the same as for Study III (2004–2009). A total of 2513 cases of OHCA 
were included where the exact geographic location of the arrest could be determined, 571 in the 
historical control group and 1942 in the intervention group. The numbers of patients 
(control/intervention) in each population density subgroup were: Rural (population density <250 
km2) 85/319, Suburban (population density 250–2999/km2) 288/832, Urban (population density 
3000–5999/km2) 149/552 and Downtown (population density >6000/km2) 49/239. No major 
differences were seen in baseline characteristics between the different population subgroups (see 
article for details). However, bystander CPR rates and the VF rate were significantly higher in the 
intervention group.   
 
5.4.1 Main results 
5.4.1.1 First responders and time intervals 
Fire-fighters were first on the scene in 54% of cases in the Rural area compared with 27% in the 
Downtown area. Fire-fighters performed CPR in the majority of cases in all subgroups; lowest in 
the Downtown area (79% of cases) and highest in the Suburban area (94% of cases).  
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The response times (i.e. dispatch to arrival) were significantly shortened in all studied subgroups. 
The most prominent time reduction was seen in the Rural group (13.5 to 10.3 minutes, p=0.001) 
compared with (5.8 to 5.0 minutes, p<0.05) the Downtown group.  
 
5.4.1.2 Population density 
In logistic regression analysis, high population density (Downtown >6000/km2) was associated 
with improved 30-day survival as compared with the most sparsely populated area (Rural 
<250/km2), after adjusting for sex, age, place of the arrest, aetiology, witnessed status, bystander 
CPR and rhythm (adjusted OR 2.1, 95% CI 1.1–4.1). 
 
5.4.1.3 30 day-survival 
As seen in Table 8, overall survival improved significantly in the intervention group compared 
with controls in the Suburban group and the Downtown group. When comparing low- and high-
density areas, the 1-month survival rates changed from 4.7 to 5.3% in the Rural area (control vs. 
intervention) and from 4.1 to 15% in Downtown.  
Table 8. Outcome in all patients and in each population subgroup (n=control/intervention). 
 
*p<0.01, **p<0.05 
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6 DISCUSSION 
6.1 DO INCREASED BYSTANDER CPR RATES IMPROVE SURVIVAL? 
The association between bystander CPR and survival was recently challenged in an editorial in 
the New England Journal of Medicine, where considerations regarding efficacy, safety and 
associated costs were taken into account, suggesting that to educate persons in CPR may be 
counterproductive instead of leading anywhere in terms of improved survival.119 However, 
despite the lack of randomised data, there is compelling evidence supporting bystander CPR as 
one of the key measures in the treatment of OHCA.60-62  
In several large observational studies with patient numbers ranging from 30,000 (as in Study I) to 
more than 100,000, the findings are very similar.36, 120 Bystander CPR has repeatedly been 
demonstrated to be an independent factor affecting survival in cases of OHCA and it is associated 
with a twofold or even a threefold increased chance of survival compared with no CPR. The 
effect of bystander CPR seems to be more marked when the delay between the arrest and the start 
of CPR is short.61, 62 Bystander CPR has been associated with an increased likelihood of VF as 
first rhythm,121 suggesting that CPR may prolong the duration of VF before deterioration to 
asystole. The results of Study I are in line with these findings, as bystander CPR was found to be 
an independent predictor of survival and was associated with an increased proportion of patients 
found in shockable rhythm.  
 
6.2 TYPE OF BYSTANDER – DOES IT MATTER? 
The category of the bystander has been shown to influence survival. Bystander CPR performed 
by healthcare professionals is associated with a higher proportion of VF and increased survival 
compared with CPR by laypersons.62, 122 Although many factors are involved, the quality of 
CPR, in terms of compression rate, depth of compression and hands-off time, is probably the 
key factor.123 However, even when EMS personnel deliver CPR the quality may be far from 
optimal, with substantial hands-off time and too shallow chest compression.124 With a CPR 
feedback device these factors have been improved among EMS providers.125 Although difficult 
to assess, one may assume that healthcare personnel find it easier to identify a cardiac arrest 
and may therefore initiate CPR more rapidly after a collapse than laypersons.  
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As shown in Study I, the proportion of laypersons performing CPR, trained or untrained, has 
increased over the last few years in Sweden. Besides the influence of educational campaigns in 
Sweden, one factor that may also have contributed to the increase is CPR guidance by 
telephone from dispatchers to untrained bystanders, which started in 1997.  
In previous studies layperson CPR has been associated with a twofold increase in the chance of 
survival compared with no CPR.122 However, the data is very limited as regards outcome and the 
level of training among lay rescuers. This has also been difficult to assess in studies involving the 
Swedish Cardiac Arrest Register, as this information is not required when the EMS crew fill in 
the register form. In some studies, survival rates have been reported to be similar when poor CPR 
has been performed by an untrained bystander versus no CPR.61 In Study I, no data existed on the 
level of training of bystanders and therefore this could not be assessed. In addition, the quality of 
CPR could not be assessed in Studies II–IV, which would have been interesting for several 
reasons. In Study II the quality of CPR might have been affected by application of the cooling 
device. In Study III, CPR quality in comparison between EMS and fire-fighters may have 
differed. In Study IV regional differences in CPR quality carried out by EMS and fire-fighters 
may have had an effect.  
 
6.3 WHAT ARE THE LIMITATIONS OF THE SWEDISH CARDIAC ARREST 
REGISTER? 
A register is no better than the quality of data recorded. Since 2009 the Swedish Cardiac Arrest 
Register has included all the EMS organisations in Sweden and it thus covers the vast majority of 
the population. However, at the start in 1990 only a few EMS organisations reported to the 
register, and the number has increased gradually. In Study I this makes comparison of data from 
the early study period (i.e. 1992–95) with that of a more recent time (i.e. 2002–2005) somewhat 
difficult, as we might have been looking at slightly different populations. At the end of the study 
period for Study I (2005) about 70% of EMS organisations were included. Thus, when missing 
data from one third of the population the results are more difficult to generalise. In addition, we 
do not know if all cases of OHCA were included in the register. One might suggest that in cases 
where the EMS crew is not playing an active part in CPR (e.g. when a public AED is used and 
ROSC is achieved prior to ambulance arrival) the reporting rate may be lower.126 Evaluating data 
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in observational studies always carries a risk that some confounding factors will not be included 
in multivariate analyses.  
 
6.4 WHY IS THE INITIAL RHYTHM SO IMPORTANT FOR SURVIVAL? 
The presence of VF as first recorded rhythm is the strongest predictor of survival in cases of 
OHCA. This well-established fact was confirmed by the results in Studies I and III. To have VF 
as first rhythm is both an indicator of the origin (i.e. cardiac origin) and the duration (i.e. before 
deteriorating to asystole) of cardiac arrest. In our material the VF rate ranged from 20% to 43%. 
However, the VF rate at the time of cardiac arrest is probably much higher. Estimations have 
been made suggesting a VF incidence of 60–70% at the time of arrest.39 In some settings, e.g. 
cardiac arrests occurring in aircraft or at public venues with an AED close by, the VF rate has 
been described as being as high as 59% to 65%.33, 45   
In Study III the use of first responders reduced the time to quality CPR and connection of an 
AED by one minute. This might be the mechanism behind the increased VF incidence seen in 
this study. In addition, high quality CPR with short pre-shock pauses and accurate chest 
compression has been shown to increase the chance of successful defibrillation and it most 
likely has a direct impact on clinical the outcome.127, 128 
 
6.5 HOW IMPORTANT IS TIME TO CPR AND DEFIBRILLATION? 
The chain-of-survival concept is focused on time to treatment. Use of survival models has 
suggested that each minute of delay to defibrillation in VF patients reduces the probability of 
survival by around 10%.60, 129 To shorten the time to high-quality CPR and defibrillation was the 
rationale behind Study III.  In previous studies, short time intervals to CPR and defibrillation 
have been shown to improve survival rates.60-62 If defibrillation can be carried out within the first 
3 to 5 minutes after cardiac arrest, survival rates well over 50% have been presented.72, 77, 79, 130 
However, the findings in Study IV suggest that the relationship between time reduction and 
survival may not be proportional (Figure 7). A relatively small gain in time in areas with a shorter 
response time seems to be more important than a substantial time reduction in regions with 
longer response times. The implication of this finding is that there might be a breakpoint where 
 32 PER NORDBERG 
 
time reduction after a certain duration is of less value. In areas with long response times of EMS 
and first responders, other ways need to be explored to recruit rescuers to the scene. 
 
6.6 WHERE DO WE HAVE THE BEST USE OF FIRST RESPONDERS? 
The results in Study III indicate an overall benefit of the use of a first responder system in cases 
of OHCA, with significantly increased 30-day- and 3-year survival. However, when assessing the 
different subpopulations we can see that the effect is outstanding in witnessed arrests and in 
patients with VF as first rhythm. This is in line with other reports and with the results of a pilot 
study preceding Study III, where none of the survivors were among non-witnessed arrests.1, 35 
The implication of this is that it might be useful to explore ways towards more restricted 
dispatching of fire-fighters, limited to only bystander witnessed cases. However, this requires a 
high level of expertise among dispatchers to rapidly identify the circumstances of the arrest. 
Furthermore, in Study III there was no benefit among patients with non-shockable rhythms in 
any of the outcome measures: ROSC, admitted alive, 30-day- or 3-year survival. These findings 
are similar to those in other first-responder studies.73, 75, 76 To improve outcome in this patient 
group remains a challenge. In Study IV we saw that dual dispatch can reduce time intervals in 
different regions with various population densities. However, the survival rate in scarcely 
populated areas was unchanged, in accordance with the results of other studies.116, 131 In this 
setting, other approaches to recruit resources might be needed.  
 
6.7 DOES THE NUMBER OF PERSONS ON THE SCENE MATTER? 
The optimal number of trained persons (i.e. EMS and first responders) on the scene during 
resuscitation in a case of OHCA is unknown. Some data exists which suggests that multiple lay 
rescuers on the scene of an arrest prior to EMS arrival could be associated with improved CPR 
quality.132 Historically, ERC ALS teaching scenarios concern four or even five people.133 One 
potential effect of the intervention in Study III was the recruitment of more skilled persons (i.e. 
fire-fighters in addition to EMS) to the scene of the arrest. Besides an earlier start of resuscitation, 
this could also mean an improved quality of ALS. Over time, one might assume that the roles of 
fire-fighters and EMS crews have become more established. As previously discussed, the number 
of persons on the scene might improve the quality of CPR.124, 127, 134 With skilled fire-fighters on  
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the scene, EMS crews are not restricted to performing CPR but can focus on the next step, such 
as drug administration and airway management. 
 
6.8 HOW IMPORTANT ARE IN-HOSPITAL FACTORS? 
Post-resuscitation care at intensive care units has improved significantly during the last decade 
and has most likely contributed to increased in-hospital survival. Therapeutic hypothermia has 
been tested in randomised controlled trials and is discussed in the next section. However, the 
level of evidence concerning other specific in-hospital measures following cardiac arrest is 
generally low and is derived mostly from observational studies, specific or combined 
interventional studies using historical controls, or small randomised series (e.g. concerning 
glucose levels).55, 88 Some of these factors are presented in Table 4.  In many aspects, this is a 
difficult population to investigate in observational studies. The risk of selection bias is 
particularly high, as many of the forms of in-hospital intervention in these patients, such as 
coronary angiography, will not be considered unless the patient shows signs of neurological 
recovery. Some in-hospital factors were considered in Study III in order to assess their potential 
impact on outcome during the study period. We could see a difference in the proportion of 
patients where angiography was performed more than 24 hours after the arrest. This may indicate 
a different approach between the control- and the intervention period concerning the use of 
coronary angiography in these patients.  
Perhaps most debated over the past few years is the potential benefit of immediate angiography 
in patients without STEMI. As in aware patients, immediate angiography is recommended in 
OHCA survivors with ST elevation, which in small studies has been associated with improved 
outcome.109, 135 Although the results of several studies have confirmed that significant lesions (up 
to 58%) and occlusions (up to 27%) may occur even in the absence of ST elevation,104-106 the 
value of immediate coronary angiography in non-STEMI cases is undetermined and this needs to 
be tested in randomised trials. 136, 137  
 
6.9 HOW SHOULD THERAPEUTIC HYPOTHERMIA BE USED?  
Brain injury is the cause of death in two-thirds of resuscitated cardiac arrest patients that are 
admitted to hospital.138 Hypothermia has been shown to have a range of neuroprotective effects 
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after cardiac arrest, limiting the effect of the global ischaemia/reperfusion injury by reducing the 
pathological mechanisms of ischaemia, decreasing cerebral metabolism, slowing the ischaemic 
loss of ion gradients and exerting anti-inflammatory effects.93 
As described earlier, in-hospital therapeutic hypothermia in VF patients has been shown to 
improve neurological function six months after cardiac arrest.94, 95, 139 Therapeutic hypothermia is 
now integrated in current guidelines and for many years has been an established treatment at 
intensive care units.55 However, this approach has been challenged recently in a large randomised 
hospital study where fever was avoided and hypothermia to 33 °C versus 36 °C was compared.96 
In this study, with a slightly different study population in comparison with the previous studies 
(e.g. all rhythms included and, except for patients with asystole, unwitnessed arrests as well) no 
differences in outcome were seen between the treatment groups. In Study III, there was no 
difference in the control and intervention groups in the proportion of patients treated by means of 
therapeutic hypothermia. In logistic regression analysis of patients admitted alive with VF as first 
rhythm, therapeutic hypothermia was not associated with improved 30-day- or 3-year survival. 
 
6.10 HOW CRUCIAL IS THE TIME TO COOLING? 
In Study II we investigated the safety and feasibility of very early induction of hypothermia as 
early as during CPR, hours before the start of cooling in most hospital studies.140 The 
pathophysiology of global ischaemic/reperfusion injury that is triggered at the time of cardiac 
arrest provides a strong argument for such intervention to avoid deleterious cellular damage.92, 93 
The immediate injuries induced by the global ischaemic/reperfusion response after OHCA are 
particularly damaging in the brain.92, 93 The current consensus of opinion is also to initiate cooling 
as soon as possible. 55, 67 The existing experimental data are convincing as regards the benefit of 
hypothermia after circulatory arrest.98, 141 These studies are mainly based on early cooling, 
induced during CPR (i.e. intra-arrest) or very soon after the circulation has been restored (i.e. 
post-ROSC), with clear superiority of rapid intra-arrest cooling over cooling initiated post-
ROSC.97 142 In addition, numerous cases of severe accidental hypothermia occurring before or 
just after cardiac arrest have shown the potential of cooling to protect the brain from injury. 143, 144 
Starting cooling at a later stage, after several hours, has not been widely tested in animals. Thus, 
when moving from very early cooling in an experimental setting to several hours of delay in 
clinical practice, we might miss the time-window for the best effectiveness of hypothermia.145  
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6.11 IS THE METHOD OF COOLING OF IMPORTANCE? 
To be able to start early intra-arrest cooling in the field a safe and reliable method is needed that 
can be used by the EMS. The predominating method used is administration of cold intravenous 
(i.v.) saline, which in several smaller studies has been shown to be safe and feasible for use intra-
arrest and post-ROSC and has resulted in a lowered temperature on hospital arrival (by 1.2 to 2.1 
°C).101, 102, 146 However, in two recent randomised clinical trials no benefit of early post-ROSC 
cooling compared with hospital cooling alone was found.99, 100 In these studies, patients were 
randomised minutes after ROSC to either i.v. cooling with up to 2 litres of cold saline or to 
standard ALS treatment. In addition, patients randomised to pre-hospital cooling in the larger 
study showed an increase in haemodynamic side-effects, with a significantly increased number of 
re-arrests, poorer oxygenation and increased pulmonary oedema at admission. These findings 
suggest that an i.v. volume load directly after ROSC may be harmful.  
In Study II, we assessed another method of in-field cooling of OHCA patients. The technique of 
trans-nasal evaporative cooling was developed primarily to cool the brain. In Study II we 
concluded that trans-nasal evaporative cooling is an easily applicable and effective cooling 
method that can be induced during cardiopulmonary resuscitation. It was safe to use, significantly 
lowered the patients’ temperature at hospital arrival and it shortened the time to achieve the target 
temperature of <34°C. The method involves continuous cooling without an i.v. volume load, 
which most likely is advantageous compared with the use of cold i.v. fluids.113, 147   
There are two on-going randomised clinical trials that have been set up to investigate the effect of 
intra-arrest cooling versus hospital cooling that will add important information to this field of 
research. One of them involves trans-nasal evaporative cooling 148 and the other one is involves 
the use of cold fluid as the pre-hospital cooling method.149 
 
6.12 SOME ETHICAL ASPECTS OF CARDIAC ARREST RESEARCH  
To perform high quality research within the field or resuscitation is a major challenge. Most of 
the studies in this field origin from experimental studies, retrospective studies, prospective 
observational studies or before/after studies. In general the level of evidence from these types of 
studies is very limited. The approaches are certainly valuable to highlight certain issues or 
generating hypothesis for future research. However, the need of randomised controlled trials is 
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essential to assess new (or old) treatments, their potential benefit and whether they are cost 
effective or not.  
There are several ethical concerns in performing research in cardiac arrest patients. One of the 
most debated issues is the informed consent procedure, which is impossible to perform in 
unconscious patients. In addition, to ask relatives for permission to enrol the person in a research 
study in this critical situation when the emphasis must be on the medical management is very 
difficult and may also delay necessary actions. Recent directives within the European Union150 
and the US151 have made research in unconscious persons more difficult when the patient’s 
autonomy cannot be ensured prior to enrolment. However, to improve the chances of survival at 
a population level, exceptions from these directives are most probably needed. In study III, the 
preceding pilot study showed very promising results on survival rates, which consequently made 
randomisation very difficult. In study II informed consent was received from all surviving 
patients and from next of kin in cases where the patients did not survive. To discuss with relatives 
about consent for a clinical study when their close relative recently died from a cardiac arrest is 
very challenging. To explore ways to reduce some of the barriers associated with performing 
research in these patients are needed to improve the quality of evidence in the treatment of 
cardiac arrest.  
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7 CONCLUSIONS 
Between 1992 and 2005 there was substantial increase in bystander CPR in cases of out-of-
hospital cardiac arrest in Sweden, performed by laypersons. Bystander CPR was associated 
with positive effects on both ventricular fibrillation and survival. 
Pre-hospital intra-arrest trans-nasal cooling is safe and feasible in cases of out-of-hospital 
cardiac arrest and is associated with a significant improvement in the time interval required to 
cool patients. 
The implementation of a dual dispatch system using fire-fighters as first responders in addition to 
EMS significantly shortened response times and was associated with substantially improved 30-
day survival and survival after 3 years in cases of out-of-hospital cardiac arrest. 
Dual dispatch of fire-fighters and EMS reduced response times in all studied regions, ranging 
from very rural areas to very densely populated areas in Stockholm. However, the effect of this 
intervention on 30-day survival rates varied depending on population density, with the lowest 
impact in the rural areas. 
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